| payload |
{"created_at":"2026-04-18T15:49:14.474 {"created_at":"2026-04-18T15:49:14.474663+00:00","signal_type":"discovery_unusual_volume_delta","source":"discovery_ingestor","url":"https://www.nasdaq.com/articles/ceo-moonlake-immunotherapeutics-dumped-shares-worth-28-million-should-investors-avoid","value":{"fp":"21877b1e7003c7f2","kind":"unusual_volume","published_at":"2026-04-18T14:37:01+00:00","source":"Nasdaq Markets","summary":"Key PointsCEO Jorge Santos da Silva sold 150,000 shares for a transaction value of approximately ~$2.75 million, based on a weighted average sale price of $18.35 per share.","tickers":[],"title":"The CEO of MoonLake Immunotherapeutics Dumped Shares Worth $2.8 Million. Should Investors Avoid the Stock?","url":"https://www.nasdaq.com/articles/ceo-moonlake-immunotherapeutics-dumped-shares-worth-28-million-should-investors-avoid"}}... |